UACC-812(人乳腺导管瘤细胞)
CBP60409
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | UACC-812 |
Background: | This cell line was established by A. Liebovitz and associates in 1986 from breast tissue removed at mastectomy to remove a ductal carcinoma (stage II, grade IV). |
Species: | Homo sapiens, human |
Tissue: | mammary gland; breast |
Disease: | ductal carcinoma |
Gender: | female, 43 years |
Morphology: | epithelial |
Growth Mode: | adherent |
Doubling Time: | 100 hrs |
DNA Profile: | Amelogenin: X CSF1PO: 11 D13S317: 12 D16S539: 8, 11 D5S818: 11, 12 D7S820: 9 THO1: 9 TPOX: 8, 11 vWA: 16 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
DMEM+20 ng/ml human EGF+20%FBS UACC-812完全培养基,# CBP60409M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | N/A |
Receptor Expression: | estrogen receptor (negative), progesterone receptor (negative) |
Oncogene: | N/A |
Genes Expressed: | N/A |
Cellular Products: | N/A |
Tumor Formation: | N/A |
Comments: | Prior to surgery, the patient had received extensive chemotherapy. The cells exhibit a 15 fold amplification of the HER-2/neu oncogene sequence. They are negative for estrogen receptors, progesterone receptors and P glycoprotein. For more information, please contact Cobioer (4008-750-250). |